Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer [Phase 3]

View source ↗

Summary

Daewoong's Phase 3 trial DWP14012 for prevention of NSAIDs-induced peptic ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease

Drugs mentioned

• DWP14012

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Peptic Ulcer | Phase 3 | Status: COMPLETED